BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2831307)

  • 1. Augmentation by 4-aminopyridine of vestibulospinal free fall responses in chronic spinal-injured cats.
    Blight AR; Gruner JA
    J Neurol Sci; 1987 Dec; 82(1-3):145-59. PubMed ID: 2831307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of vestibular and auditory startle responses in the rat and cat.
    Gruner JA
    J Neurosci Methods; 1989 Feb; 27(1):13-23. PubMed ID: 2537448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The vestibulospinal free fall response: a test of descending function in spinal-injured cats.
    Gruner JA; Young W; DeCrescito V
    Cent Nerv Syst Trauma; 1984; 1(2):139-59. PubMed ID: 6336248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 4-aminopyridine on axonal conduction-block in chronic spinal cord injury.
    Blight AR
    Brain Res Bull; 1989 Jan; 22(1):47-52. PubMed ID: 2540887
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parallel Evaluation of Two Potassium Channel Blockers in Restoring Conduction in Mechanical Spinal Cord Injury in Rat.
    Page JC; Park J; Chen Z; Cao P; Shi R
    J Neurotrauma; 2018 May; 35(9):1057-1068. PubMed ID: 29228863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in pharmacological sensitivity of the spinal cord to potassium channel blockers following acute spinal cord injury.
    Fehlings MG; Nashmi R
    Brain Res; 1996 Oct; 736(1-2):135-45. PubMed ID: 8930318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conduction block in acute and chronic spinal cord injury: different dose-response characteristics for reversal by 4-aminopyridine.
    Shi R; Kelly TM; Blight AR
    Exp Neurol; 1997 Dec; 148(2):495-501. PubMed ID: 9417828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel potassium channel blocker, 4-AP-3-MeOH, inhibits fast potassium channels and restores axonal conduction in injured guinea pig spinal cord white matter.
    Sun W; Smith D; Fu Y; Cheng JX; Bryn S; Borgens R; Shi R
    J Neurophysiol; 2010 Jan; 103(1):469-78. PubMed ID: 19923250
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 4-Aminopyridine-sensitive neurologic deficits in patients with spinal cord injury.
    Hayes KC; Potter PJ; Wolfe DL; Hsieh JT; Delaney GA; Blight AR
    J Neurotrauma; 1994 Aug; 11(4):433-46. PubMed ID: 7837283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential effects of low and high concentrations of 4-aminopyridine on axonal conduction in normal and injured spinal cord.
    Shi R; Blight AR
    Neuroscience; 1997 Mar; 77(2):553-62. PubMed ID: 9472411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acrolein-mediated conduction loss is partially restored by K⁺ channel blockers.
    Yan R; Page JC; Shi R
    J Neurophysiol; 2016 Feb; 115(2):701-10. PubMed ID: 26581866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of 4-aminopyridine on neurological deficits in chronic cases of traumatic spinal cord injury in dogs: a phase I clinical trial.
    Blight AR; Toombs JP; Bauer MS; Widmer WR
    J Neurotrauma; 1991; 8(2):103-19. PubMed ID: 1870134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potassium channel blocker, 4-aminopyridine-3-methanol, restores axonal conduction in spinal cord of an animal model of multiple sclerosis.
    Leung G; Sun W; Brookes S; Smith D; Shi R
    Exp Neurol; 2011 Jan; 227(1):232-5. PubMed ID: 21093437
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Axonal physiology of chronic spinal cord injury in the cat: intracellular recording in vitro.
    Blight AR
    Neuroscience; 1983 Dec; 10(4):1471-86. PubMed ID: 6664497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury: a double-blinded, placebo-controlled crossover trial.
    Wolfe DL; Hayes KC; Hsieh JT; Potter PJ
    J Neurotrauma; 2001 Aug; 18(8):757-71. PubMed ID: 11526982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of 4-aminopyridine on motor evoked potentials in patients with spinal cord injury.
    Qiao J; Hayes KC; Hsieh JT; Potter PJ; Delaney GA
    J Neurotrauma; 1997 Mar; 14(3):135-49. PubMed ID: 9104931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recording of spared motor evoked potentials and its augmentation by 4-aminopyridine in chronic spinal cord-injured rats.
    Yu K; Li J; Rong W; Jia L; Yuan W; Ye X; Shi Z; Dai B
    Chin Med J (Engl); 2001 Feb; 114(2):155-61. PubMed ID: 11780197
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 4-Aminopyridine derivatives enhance impulse conduction in guinea-pig spinal cord following traumatic injury.
    McBride JM; Smith DT; Byrn SR; Borgens RB; Shi R
    Neuroscience; 2007 Aug; 148(1):44-52. PubMed ID: 17629412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose responses of three 4-aminopyridine derivatives on axonal conduction in spinal cord trauma.
    McBride JM; Smith DT; Byrn SR; Borgens RB; Shi R
    Eur J Pharm Sci; 2006 Feb; 27(2-3):237-42. PubMed ID: 16297607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of axonal dysfunction in an in vitro model of acute compressive injury to adult rat spinal cord axons.
    Fehlings MG; Nashmi R
    Brain Res; 1995 Apr; 677(2):291-9. PubMed ID: 7552255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.